Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011-2021.
Joseph R HergesRodolfo J GalindoJoshua J NeumillerHerbert C HeienGuillermo E UmpierrezRozalina Grubina McCoyPublished in: Diabetes care (2023)
Glucagon fill rates are concerningly low and declined between 2011 and 2021 but increased in appropriate subgroups with type 1 diabetes, using short-acting insulin, or with a history of severe hypoglycemia. Fill rates were disproportionately low among minority patients and individuals with low income.
Keyphrases
- type diabetes
- glycemic control
- end stage renal disease
- ejection fraction
- newly diagnosed
- cardiovascular disease
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- early onset
- emergency department
- adipose tissue
- skeletal muscle
- metabolic syndrome
- patient reported outcomes
- insulin resistance
- weight loss
- adverse drug